Complement activation and cytokine production as consequences of immunological bioincompatibility of extracorporeal circuits

Cazenave, 1986, Blood-surface interactions 1992 Kinoshita, 1991, Overview of complement biology, Immunol. Today, 12, 291, 10.1016/0167-5699(91)90001-A Isenmann, 1981, Nucleophilic modification of human complement protein C3: corre lation of conformational changes with acquisition of C3b-like functional properties, Biochemistry, 20, 4458, 10.1021/bi00518a034 Cheung, 1989, Analysis of the complement fragments with hemodialysis membranes, Kidney Int., 35, 576, 10.1038/ki.1989.26 Farries, 1991, Evolution of the complement system, Immunol. Today, 12, 295, 10.1016/0167-5699(91)90002-B Kazatchkine, 1982, The human alterantive complement pathway: biology and immunopathology of activation and regulation, Progr. Allerg, 30, 193 Pascual, 1988, Metabolism of complement factor D in renal failure, Kidney Int., 34, 529, 10.1038/ki.1988.214 Carreno, 1988, The ability of sephadex to activate human complement pathway is suppressed in specifically substituted functional sephadex derivatives, Mol. Immunol, 25, 165, 10.1016/0161-5890(88)90064-8 Carreno, 1989, Regulation of the human alternative complement pathway: formation of the ternary com plex between factor H surface-bound C3b and chemical groups on nonactivating surfaces, Eur. J. Immunol., 19, 2145, 10.1002/eji.1830191126 Crepon, 1987, Molecular weight dependence of the acquired anticomplementary and anticoagulant activities of specifically substituted dextran, Biomaterials, 8, 248, 10.1016/0142-9612(87)90111-6 Kazatchkine, M. D., Fearon, D. T., Silbert, J. E. & Austen, K. F., Surface associated heparin inhibits zymosan-induced activation of the human alternative complement pathway by augmenting the regulatory action of the control proteins on particule-bound C3b. J. Exp. Med.150 1202–1215. Shenkein, 1981, The role of immunoglobulins in alternative complement pathway activation by zymosan. I. Human IgG with specificity for zymosan enhances alternative pathway activation by zymosan, J. Immunol., 126, 7, 10.4049/jimmunol.126.1.7 Moore, 1981, IgG on mouse erythrocytes augments activation of the human alternative pathway by enhancing deposition of C3b, J. Immunol., 126, 1805, 10.4049/jimmunol.126.5.1805 Carreno, M. P., Maillet, F., Labarre, P., Jozefovicz, M. & Kazatchkine, M. D., Specific antibodies enhance Sephadex-induced activation of the alternative complement pathway in human serum. Biomaterials, 9 514–518. Maillet, 1991, Specific antibodies enhance alternative complement pathway activation by cuprophane, Nephrol. Dial. Transplant., 6, 193, 10.1093/ndt/6.3.193 Cooper, 1985, The classical complement pathway: activation and regulation of the first complement component, Adv. Immunol., 37, 151, 10.1016/S0065-2776(08)60340-5 Müller-Eberhard, 1985, Complement chemistry and pathways, 21 Fiedel, 1976, Complement activation by interaction of polyanions and polycations, Immunology, 30, 161 Ahearn, J. M., Fearon, D. T., Structure and function of the complement receptors CR1 (CD35) and CR2 (CD21). Adv. Immunol.46 183–218. Klickstein, 1988, Identification of distinct C3b and C4b recognition sites in the human C3b/C4b receptor (CR1, CD35) by deletion mutagenesis, J. Exp. Med., 168, 1699, 10.1084/jem.168.5.1699 Weiss, 1988, Regulation of the immune response by human C3 receptors, Bailliére's Clin. Immuno. Allergy, 2, 387 Wright, 1983, Identification of the C3bi receptor of human monocytes and macrophages by using monoclonal antibodies, 80, 5699 Sanchez Madrid, 1983, A human leukocyte differentiation family with distinct alpha subunits and a common beta subunit: the lymphocyte function-associated antigen (LFA-1), the Obi complement receptor (OKMI/Mac1), and the p150,95 molecule, J. Exp. Med., 158, 1785, 10.1084/jem.158.6.1785 Myones, 1988, Neutrophil and monocyte cell surface p159,95 has iC3breceptor (CR4) activity resembling CR3, J. Clin. Invest., 82, 640, 10.1172/JCI113643 Berger, 1984, Human neutrophils increase expression of Obi as well as Cab receptors upon activation, J. Clin. Invest, 74, 1566, 10.1172/JCI111572 Couturier, 1990, Induction of cell-associated IL-1 through stimulation of the adhesion-promoting protein LFA-i (CDlla/CD18) and CR3 (CDllb/CD18) of human monocytes, Eur. J. Immunol., 20, 999, 10.1002/eji.1830200508 Bhakdi, 1988, Relative inefficiency of terminal complement activation, J. Immunol., 141, 3117, 10.4049/jimmunol.141.9.3117 Hugh, 1981, Isolation of three separate anaphylatoxins from complement-activated human serum, Mol. Cell. Biochem., 41, 59, 10.1007/BF00225297 Bokisch, 1970, Anaphylatoxin inactivator of human plasma: its isolation and characterization as a car☐ypeptidase, J. Clin. Invest., 49, 2427, 10.1172/JCI106462 Vogt, 1986, Possible roles of anaphylatoxins in disease, Complement, 3, 177, 10.1159/000467894 Craddock, 1977, Complement (C5a)induced granuloctye aggregation in vitro: a possible mechanism for complement-mediated leukostasis and leukopenia, J. Clin, Invest., 60, 260, 10.1172/JCI108763 Hugh, 1986, Biochemistry and biology of anaphylatoxins, Complement, 3, 11 Haeffner-Cavaillon, 1987, C3a/C3adesArg induces production and release of interleukin-1 by cultured human monocytes, J. Immunol., 139, 794, 10.4049/jimmunol.139.3.794 Rollins, 1991, Purification of the active C5a receptor from human polymorphonuclear leukocytes as a receptor-Gi complex, 88, 971 Chenoweth, 1983, Anaphylatoxin formation during hemodialysis: effect of different dialyser membranes, Kidney Int., 24, 764, 10.1038/ki.1983.225 Arnaout, 1985, Increased expression of an adhesion-promoting surface glycoprotein in the granulocytopenia of hemodialysis, New Engl. J. Med., 312, 457, 10.1056/NEJM198502213120801 Hörl, 1990, Plasma levels of main granulocyte components during hemodialysis, Am. J. Nephrol., 10, 53, 10.1159/000168054 Till, 1982, Intravascular activation of complement and acute lung injury, J. Clin. Invest., 69, 1126, 10.1172/JCI110548 Ward, 1985, Complement activation, lung injury and products of lipid peroxydation, J. Clin. Invest., 76, 517, 10.1172/JCI112001 Hammerschmidt, 1980, Association of complement activation and elevated plasma C5a with adult respiratory distress syndrome: pathophysiologicai relevance and possible prognostic value, Lancet, 1, 947, 10.1016/S0140-6736(80)91403-8 Cheung, 1986, Cardiopulmonary effects of cuprophane-activated plasma in swine: role of complement products, Kidney Int., 29, 799, 10.1038/ki.1986.69 Okuzawa, 1989, C5a induction of human interleukin-1 synergistic effect with endotoxin or interferon gamma, J. Immunol., 139, 2635, 10.4049/jimmunol.139.8.2635 Shindler, 1990, Transcription not synthesis of Interleukin-1 and tumor necrosis factor α by complement, Kidney Int., 37, 85, 10.1038/ki.1990.12 Bhakdi, 1988, Function and relevance of the terminal complement sequence, Baillìere's Clin. Immunol. Allergy., 2, 363 Preissner, 1985, Self-association of the seventh component of human complement (C7): dimerization and polymerization, J. Immunol., 135, 452, 10.4049/jimmunol.135.1.452 Tschopp, 1982, Formation of transmembrane tubules by spontaneous polymerization of hydrophilic complement protein C9, Nature, 298, 534, 10.1038/298534a0 Zalman, 1986, Isolation of a human erythrocyte membrane protein capable of inhibiting expression of homologous complement transmembrane channels, 83, 6975 Morgan, 1987, Recovery of human neutrophils from complement attack: removal of the membrane attack complex by endocytosis and exocytosis, J. Immunol., 138, 246, 10.4049/jimmunol.138.1.246 Salama, 1988, Deposition of terminal C5b-9 complement complexes on erythrocytes and leukocytes during cardio-pulmonary bypass, New Engl. J. Med., 318, 408, 10.1056/NEJM198802183180704 Sieger, 1986, Noncytolytic terminal complement may serve as calcium gates to elicit leukotriene B4 generation in human polymorphonuclear leukocytes, J. Immunol., 137, 1286, 10.4049/jimmunol.137.4.1286 Jenne, 1985, Molecular cloning of S-protein, a link between complement, coagulation, and cell substrate adhesion, EMBO J., 4, 3153, 10.1002/j.1460-2075.1985.tb04058.x Bhakdi, 1983, A simple immunoradiometric assay for the terminal SCSb-9 complex of human complement, J. Immunol. Meth., 57, 283, 10.1016/0022-1759(83)90088-1 Hugo, 1987, Sensitive ELISA for quantitating the terminal membrane: C5b-9 and fluid phase SC5b-9 complex of human complement, J. Immunol. Meth., 99, 243, 10.1016/0022-1759(87)90134-7 Kim, 1975, Adsorption of blood proteins onto polymer surfaces, Adv. Chem. Series., 145, 218, 10.1021/ba-1975-0145.ch010 Kochwa, 1977, Blood elements at foreign surfaces: a biochemical approach to the study of the adsorption of plasma proteins, Ann. N. Y. Acad. Sci., 283, 37, 10.1111/j.1749-6632.1977.tb41751.x Chuang, 1983, Adsorption and reactivity of human fibrinogen and immunoglobulin G on two types of hemodialysis membranes, Int. J. Artif. Organs., 6, 199 Craddock, 1977, Hemodialysis leukopenia: pulmonary vascular leukostasis resulting from complement activation by dialyser cellophane membranes, J. Clin. Invest., 59, 879, 10.1172/JCI108710 Cheung, 1986, Effects of complement activation by dialysis membrane, Am. J. Nephrol., 6, 81, 10.1159/000167060 Wegmuller, 1986, Biocompatibility of different hemodialysis membranes: activation of complement and leukopenia, Int. J. Artif. Organs, 9, 85 Descamps-Latscha, 1991, Establishing the relationship between complement activation and stimulation of phagocyte oxidative metabolism in hemodialyzed patients: a randomized prospective study, Nephron, 59, 279, 10.1159/000186565 Hakim, 1984, Complement activation and hypersensitivity reactions to dialysis membranes, New Engl. J. Med., 311, 878, 10.1056/NEJM198410043111403 Amadori, 1983, Hemodialysis leukopenia and complement function with different dialyzers, Kidney Int., 24, 775, 10.1038/ki.1983.227 Cheung, 1990, Activation of complement by hemodialysis membranes: polyacrylonitrile binds more C3a than cuprophane, Kidney Int., 37, 1055, 10.1038/ki.1990.85 Parker, 1972, Changes in serum complement and immunoglobulins following cardio-pulmonary bypass, Surgery., 71, 824 Chenoweth, 1981, Complement activation during cardiopulmonary bypass, New Engl. J. Med., 304, 497, 10.1056/NEJM198102263040901 Kirklin, 1983, Complement and damaging effects of cardiopulmonary bypass, J. Thorac. Cardiovasc. Surg., 86, 845, 10.1016/S0022-5223(19)39061-0 Van Oeveren, W., Kazatchkine, M. D., Descamps-Latscha, B., Maillet, F., Fischer, E., Carpentier, A. & Wildevuur, C. R. H., Deleterious effects of cardiopulmonary bypass: a prospective study of bubble versus membrane oxygenation. J. Thorac. Cardovasc. Surg., 89 888–889. Kirklin, 1986, Effects of protamine adminstration after cardiopulmonary bypass on complement, blood elements, and the hemodynamic state, Ann. Thorac. Surg., 41, 193, 10.1016/S0003-4975(10)62668-9 Videm, 1991, Biocompatibility of extracorporeal circulation. In vitro comparison of heparin-coated and uncoated oxygenator circuits, J. Thorac. Cardiovasc. Surg., 101, 654, 10.1016/S0022-5223(19)36696-6 Videm, 1991, Reduced granulocyte activation with heparin-coated device in an in vitro model of cardiopulmonary bypass, Artif. Organs., 15, 90, 10.1111/j.1525-1594.1991.tb00766.x McLeod, 1983, Complement activation by plasmm separator membranes, Transfusion., 23, 143, 10.1046/j.1537-2995.1983.23283172853.x Rietschel, 1988, Bacterial endotoxins: properties and structure of biologically active domains, 1 Haeffner-Cavaillon, N., Cavaillon, J-M. & Szabo, L., Cellular receptors for endotoxins. In Handbook of Endotoxin, Vol. 3, (ed.) Berry, L. J., pp. 1–24. Wright, S. D., Ramos, R. A., Tobias, P. S., Ulevitch, R. J. & Mathison, J. C. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science, 249 1431-3. Couturier, C., Jahns, G., Kazatchkine, M. D. & Haeffner-Cavaillon, N., Molecules which trigger the production of IL-1 and TNF-alpha from endotoxin-stimulated human monocytes. Eur. J. Immunol., (in press). Wright, 1989, CR3 (CD11b/CD18) expresses one binding site for Arg-Gly-Asp-containing peptides, and a second site for bacterial lipopolysaccharide, J. Exp. Med., 169, 175, 10.1084/jem.169.1.175 Wright, 1989, Lipopolysaccharide binding protein opsonizes LPSbearing particles for recognition by a novel receptor on macrophages, J. Exp. Med., 170, 1231, 10.1084/jem.170.4.1231 Couturier, 1991, Binding sites for endotoxins (lipopolysaccharides) on human monocytes, J. Immunol., 147, 1899, 10.4049/jimmunol.147.6.1899 Morrison, 1991, Characterization of endotoxin specific receptors on mam malian lymphoreticular cells, Circulatory Shock., 34, 45 Morrison, 1990, Diversity of mammalian macromolecules which bind to bacterial lipopolysaccharides, 183 Hale, 1986, Pathophysiology of endotoxin shock in man, 1 Van Bossuyt, 1988, Endotoxin injection affects the Kupffer cell morphology in the rat liver, 161 Michie, 1988, Detection of circulation tumor necrosis factor after endotoxin administration, 318, 1481 Cannon, 1990, Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever, J. Infect. Dis., 161, 79, 10.1093/infdis/161.1.79 Munoz, 1991, Dysregulation of in vitro cytokine production by monocytes during sepsis, J. Clin. Invest., 88, 1747, 10.1172/JCI115493 Herbelin, 1990, Influence of uremia and hemodialysis on circulating interleukin-1 and tumor necrosis factor α, Kidney Int., 37, 116, 10.1038/ki.1990.16 Cavaillon, 1992, Serum IL-6 in long term hemodialysed patients, Nephron., 60, 307, 10.1159/000186770 Herbelin, 1991, Elevated circulating levels of interleukin-6 in patients with chronic renal failure, Kidney Int., 39, 954, 10.1038/ki.1991.120 Cavaillon, 1990, Cytokine response by monocyte/marcophages to free the lipoprotein-bound lipopolysaccharide, Infect. Immun., 58, 2375, 10.1128/IAI.58.7.2375-2382.1990 Cavaillon, 1990, Signals involved in IL-1 synthesis and release by LPS-stimulated monocyte/macrophages, Cytokine., 2, 313, 10.1016/1043-4666(90)90061-W Auron, 1987, The structure and regulation of the human prointerleukin-1 beta gene, Ann. Inst. Pasteur Immunol., 138, 462, 10.1016/S0769-2625(87)80058-2 Singer, 1988, Interleukin-1β is localized in the cytoplasmic ground substance but is largely absent from the golgi apparatus and plasma membrane of stimulated human monocytes, J. Exp. Med., 167, 389, 10.1084/jem.167.2.389 Matsushima, 1986, Intercellular localization of human monocytes associated interleukin-1 activity and release of biological active IL-1 from monocytes by trypsin and plasmin, J. Immunol., 136, 2883, 10.4049/jimmunol.136.8.2883 Carter, 1990, Purification, cloning, expression and biological characterization of an interleukin-1 receptor anatgonist protein, Nature., 344, 633, 10.1038/344633a0 Young, 1972, An invertabrate coagulation system activated by endotoxin: evidence for enzymatic activation, J. Clin. Invest., 51, 1790, 10.1172/JCI106980 Robinson, 1975, Lack of clinical usefulness of the Limulus test in the diagnosis of endotoxemia, New Engl. J. Med., 193, 421 Iwanaga, 1978, Chromogenic substrates for horseshow crab clotting enzyme. Its application for the assay of bacterial endotoxins, Hemostasis., 7, 183 Thomas, 1984, Comparative investigation of a quantitative chromogenic endotoxin assay and blood cultures, Am. J. Clin. Path., 82, 203, 10.1093/ajcp/82.2.203 Elin, 1973, Non specificity of the limulus amebocyte lysate test: Positive reactions with polynucleotides and proteins, J. Infect. Dis., 128, 349, 10.1093/infdis/128.3.349 Mikami, 1982, Gelation of amebocyte lysate by simple polysaccharides, Microbiol. Immunol., 26, 403, 10.1111/j.1348-0421.1982.tb00190.x Suzuki, 1977, Gelation of limulus lysate by synthetic dextran derivatives, Microbiol. Immunol., 21, 419, 10.1111/j.1348-0421.1977.tb00307.x Stumacher, 1973, Limitation of the usefulness of the Limulus assay of endotoxin, New Engl. J. Med., 288, 1261, 10.1056/NEJM197306142882402 Jorgensen, 1986, Clinical applications of the limulus amebocyte lysate test, 127 Laude-Sharp, 1990, Dissociation between the interlukm 1-inducing capacity and limulus reactivity of lipopoiysaccharides from gram-negative bacteria, Cytokine, 2, 253, 10.1016/1043-4666(90)90025-O Haeffner-Cavaillon, 1989, Interleukin-1 induction by lipopolysaccharides: structural requirement of the 3 deoxy-D-manno-2-octulosonic acid (KDO), Mol. Immunol., 26, 485, 10.1016/0161-5890(89)90108-9 Yamagami, 1990, Detection of endotoxin antibody in longterm dialysis patients, Int. J. Artif. Organs., 13, 205, 10.1177/039139889001300403 Hindman, 1975, Pyrogenic reactions during hemodialysis caused by extramural endotoxin, Lancet., 2, 732, 10.1016/S0140-6736(75)90721-7 Raij, 1973, Endotoxinemia in febrile reactions during hemodialysis, Kidney Int., 4, 57, 10.1038/ki.1973.79 Kolmos, 1984, Bacterial contamination of the blood compartment originating from the dialysate in hemodialysers, J. Hosp. Infect., 5, 70, 10.1016/0195-6701(84)90103-8 Bingel, 1986, Human interleukin-1 production during hemodialysis, Nephron., 43, 161, 10.1159/000183822 Lonneman, 1988, Detection of endotoxin-like interleukin-l-inducing activity during in vitro dialysis, Kidney Int., 33, 29, 10.1038/ki.1988.5 Bernick, 1981, In vivo studies of dialysis-related endotoxinemia and bacteremia, Nephron., 27, 307, 10.1159/000182076 Port, 1983, Pyrogen and endotoxin reactions during hemodialysis, Contrib. Nephrol., 36, 100, 10.1159/000407586 Jenkins, 1987, Pyrogenic reactions and pseudomonas bacteremias in a hemodialysis center, Nephroi. Dial. Transplant., 16, 192 Laude-Sharp, 1990, Induction of IL-1 during hemodialysis: transmembrane passage of intact endotoxins through high permeability and cuprophane membranes, Kidney Int., 38, 1084, 10.1038/ki.1990.317 Bommer, 1987, No evidence for endotoxin transfer across high flux polysulfone membranes, Clin. Nephr., 27, 278 Haeffner-Cavaillon, 1989, In vivo induction of interleukin-1 during hemodialysis, Kidney Int., 35, 1212, 10.1038/ki.1989.112 Nilson, 1990, Endotoxins in cardiopulmonary bypass, J. Thorac, Cardiovasc. Surg., 100, 777, 10.1016/S0022-5223(19)35477-7 Rocke, 1987, Presence of circulating endotoxins during cardiac operation, J. Thorac, Cardiovasc, Surg., 93, 832, 10.1016/S0022-5223(19)37043-6 Jacob, 1980, Complement-induced granulocyte aggregation, New Engl. J. Med., 302, 789, 10.1056/NEJM198004033021407 Jacob, 1980, Leukopenia hypoxia and complement function with different hemodialysis membranes, Kidney Int., 18, 505, 10.1038/ki.1980.164 Hakim, 1982, Hemodialysis-associated neutropenia and hypoxia: the effect of dialyzer membrane materials, Nephron., 32, 32, 10.1159/000182728 Craddock, 1977, Hemodialysis leukopenia: pulmonary vascular leukostasis resulting from complement activa tion by dialyzer cellophane membranes, J. Clin. Invest., 59, 879, 10.1172/JCI108710 Craddock, 1977, Complement and leukocytemediated pulmonary dysfunction in hemodialysis, New Engl. J. Med., 296, 769, 10.1056/NEJM197704072961401 Toren, 1970, Pulmonary bed sequestration of neutrophils during hemodialysis, Blood., 36, 337, 10.1182/blood.V36.3.337.337 Hammerschmidt, 1981, Complement activation and neutropenia during cardiopulmonary bypass, J. Thorac. Cardiovasc. Surg., 81, 370, 10.1016/S0022-5223(19)37600-7 Camussi, 1981, Mediators of immune complex-induced aggregation of polymorphonuclear neutrophils. II. Platelet-activating factor as the effector substance of immune-induced aggregation, Int. Arch. Allergy Appl. Immunol., 64, 25, 10.1159/000232671 Cheung, 1991, Adherence of neutrophils to hemodialysis membranes: role of complement receptors, Kidney Int., 40, 1123, 10.1038/ki.1991.324 Kolb, 1990, Kinetics of pulmonary leukocyte sequestration in man during hemodialysis with different membrane-types, Int. J. Artif. Organs., 13, 729, 10.1177/039139889001301104 Haeffner-Cavaillon, 1990, Induction of interleukin-1 production in patients undergoing cardiopulmonary bypass, J. Thorac. Cardiovasc. Surg., 98, 1100, 10.1016/S0022-5223(19)34325-9 Hermann, 1988, Interleukin-1 stimulates T lymphocytes to produce granulocyte-monocyte colony-stimulating factor, J. Clin,. Invest., 81, 1415, 10.1172/JCI113471 Henderson, 1983, Hemodialysis hypotension: the interleukin hypothesis, Blood Purification., 1, 3, 10.1159/000166438 Bingel, 1980, Plasma interleukin-1 activity during hemodialysis, Nephron., 50, 273, 10.1159/000185186 Dinarello, 1988, Biology of interleukin-1, FASEB J., 2, 108, 10.1096/fasebj.2.2.3277884 Dinarello, 1988, Interleukin1 and its relevance in patients treated with hemodialysis, Kidney Int., 33, 21 Webb, 1988, Interleukin-1 gene assigned to long arm of human chromosome 2, Lymphokine Res., 5, 77 Lafarge, 1989, The human interleukin-1 alpha gene is located on the long arm of chromosome 2 at band q 13, Blood., 73, 104, 10.1182/blood.V73.1.104.104 Lenardo, 1989, NFkB: a pleiotropic mediator of inducible and tissue-specific gene control, Cell., 58, 227, 10.1016/0092-8674(89)90833-7 Bauerle, 1988, IkB: a specific inhibitor of the NFkB transcription factor, Science., 242, 540, 10.1126/science.3140380 Mosley, 1987, The interleukin-1 receptor binds the human interleukin-1 alpha precursor but not the interleukin-1 beta precursor, J. Biol. Chem., 262, 2941, 10.1016/S0021-9258(18)61450-4 Black, 1988, Genera tion of biologically active interleukin-1β by proteolytic cleavage of the inactive precursor, J. Biol. Chem., 263, 9342, 10.1016/S0021-9258(19)76559-4 Conlon, 1987, Localization of human mononuclear cell interleukin-1, J. Immunol., 139, 98, 10.4049/jimmunol.139.1.98 Hurme, 1989, Comparison of interleukin-1 release and interleukin-1 mRNA expression of human monocytes activated by bacterial lipopolysaccharide or synthetic Lipid A, Scand. J. Immunol., 30, 259, 10.1111/j.1365-3083.1989.tb01209.x Caroff, 1980, Inability of pyrogenic, purified Bordetella pertussis Lipid A to induce interleukin-I release by human monocytes, Infect. Immunity., 54, 465, 10.1128/IAI.54.2.465-471.1986 Dinarello, 1986, Interleukin-1: amino acid sequences, multiple biological activities and comparison with tumor necrosis factor (Cachectin), Vol. 2, 68 Sims, 1988, cDNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily, Science., 241, 585, 10.1126/science.2969618 Sims, 1989, Cloning the interleukin-1 receptor from human T cells, 86, 8946 Bomsztyk, 1989, Evidence for different interleukin-1 receptors in murine B and T cell lines, 86, 8034 Chizzonite, 1989, Two high-affinity interleukin 1 receptors represent separate gene products, 86, 8029 Eisenberg, 1990, Primary structure and functional expression from com plementary DNA of a human interleukin-1 receptor antagonist, Nature., 343, 341, 10.1038/343341a0 Dinarello, 1991, Interleukin 1 and interleukin antagonism, Blood., 77, 1629, 10.1182/blood.V77.8.1627.1627 Dinarello, 1992, Interleukin-1 and tumor necrosis factor and their naturally occuring antagonists during hemodialysis, Kidney Int., 38, 68 Wahl, 1992, Transforming growth factor β in inflammation: A cause and a cure, J. Clin. Immunol., 12, 61, 10.1007/BF00918135 Lonnemann, 1987, Plasma interleukin-1 activity in humans undergoing hemodialysis with regenerated cellulosic membranes, Lymphokine Res., 6, 63 Erben, 1987, Microbiologic contamination of liquid bicarbonate for hemodialysis, Trans. Am. Soc. Artif. Int. Organs., 33, 269 Cavaillon, 1990, Recombinant C5a enhances interleukin-1 and tumor necrosis factor release by lipopolysaccharide-stimulated monocytes and macrophages, Eur. J. Immunol., 20, 253, 10.1002/eji.1830200204 Luger, 1987, Blood-membrane interaction in hemodialysis leads to increased cytokine production, Kidney Int., 32, 84, 10.1038/ki.1987.175 Miller, 1988, Human monocyte/ macrophage activation and interleukin-1 generation by biomedical polymers, J. Biomed. Mater. Res., 22, 713, 10.1002/jbm.820220805 Tracey, 1989, Cachectin/ tumor necrosis factor, Lancet, i, 1122, 10.1016/S0140-6736(89)92394-5 Ziegler, 1988, Tumor necrosis factor in humans, New Engl. J. Med., 318, 1533, 10.1056/NEJM198806093182309 Dinarello, 1986, Tumor necrosis factor is an endoge neous pyrogen and induces production of interleukin-1, J. Exp. Med., 163, 1433, 10.1084/jem.163.6.1433 Libby, 1986, Endotoxin and TNFα induce IL-1 gene expression in adult human vascular endothelial cells, Am. J. Pathol., 124, 179 Strieter, 1989, Endothelial cell gene expression of a neutrophil chemotactic factor by TNFα, LPS and Il-1β, Science, 243, 1467, 10.1126/science.2648570 Pertosa, 1991, Involvement of peripheral blood monocytes in hemodialysis: in vivo induction of TNFα, IL-6 and β-2 microglobulin, Nephrol. Dial, Transplant., 2, 18 Seckinger, 1988, Human inhibitor of tumor necrosis factor α, J. Exp. Med., 167, 1511, 10.1084/jem.167.4.1511 Vercellotti, 1985, Oxygen radical-induced erythrocyte hemolysis by neutrophils. Critical role of iron and lactoferrin, J. Clin. Invest., 76, 956, 10.1172/JCI112095 Whorton, 1985, Effect of hydrogen peroxide on prostaglandin production and cellular integrity in cultured porcine aortic endothelial cells, J. Clin. Invest., 76, 295, 10.1172/JCI111960 Descamps-Latscha, 1982, Chemiluminescence in microamounts of whole blood for investigation of the human phagocyte oxidative metabolism function, Ann. Immunol., 133C, 349 Descamps-Latscha, 1986, Hemodialysis-membraneinduced phagocyte oxidative metabolism activation and interleukin-1 production, Life Support Syst., 4, 349 Bender, 1983, Exposure of human neutrophils to chemotactic factors potentiates activation of the respiratory burst enzyme, J. Immunol., 130, 2316, 10.4049/jimmunol.130.5.2316 Hällgren, 1981, Hemodialysisinduced increase in serum lactoferrin and serum eosinophil cationic protein as signs of local neutrophil and eosinophil degranulation, Nephron, 29, 233, 10.1159/000182379 Hörl, 1985, Plasma levels of granulocyte elestase during hemodialysis: effects of different dialyzer membranes, Kidney Int., 28, 791, 10.1038/ki.1985.199 Tetta, 1991, Leukocyte-derived mediators and biocompatibility, Nephrol. Dial. Transplant, suppl., 2, 24 Camussi, 1986, Potential role of platelet-activating factor in renal pathophysiology, Kidney Int., 29, 469, 10.1038/ki.1986.23 Montruchio, 1986, Cardiovascular alteration in the rabbit infused with platelet-activating factor (PAF): effect of Kadsurenone, a PAF-receptor antagonist, Int. J. Tissue React., 8, 497 Camussi, 1978, Mechanism involved in acute granulocytopenia in hemodialysis. Cell-membrane direct interactions, Int. J. Artif. Organs., 1, 123 Tetta, 1989, The production of platelet-activating factor during hemodialysis, Int. J. Artif. Organs., 12, 766, 10.1177/039139888901201206 Reane, 1977, Incidence and type of infection occurring in 445 chronic hemodialyzed patients, Trans. Am. Soc. Art jf Int. Organs., 23, 41, 10.1097/00002480-197700230-00012 Hirabayashi, 1988, Oxidative metabolism and phagocytosis of polymorphonuclear leuko cytes in patients with chronic renal failure, Nephron, 49, 305, 10.1159/000185081 Briggs, 1983, Leukocyte metabolism and function in uremia, Kidney Int., 24, S93 Huttenen, 1984, The neutrophil function of uremic patients treated by hemodialysis or CAPD, Scand. J. Urol. Nephrol., 18, 167, 10.3109/00365598409182185 Cantinieaux, 1988, Impaired neutrophil defense against Yersinia enterocolitica in patients with iron overload who are undergoing dialysis, J. Lab. Clin. Med., 111, 524 Bauer, 1983, Leukocyte function tests during hemodialysis with different dialysis membranes, Contr. Nephrol., 36, 9, 10.1159/000407574 Lewis, 1987, Neutrophil and monocyte alterations in chronic dialysis patients, Am. J. Kidney Dis., 9, 381, 10.1016/S0272-6386(87)80141-5 Vanholder, 1991, Phagocytosis in uremic and hemodialysis patients: a prospective and cross-sectional study, Kidney Int., 39, 320, 10.1038/ki.1991.40 Klinkmann, H., Cambi, V., Davison, A.M., Kumitomo, T. & Menta, R., Biocompatibility of hemodialysis systems: present and futureNephrol. Dial. Transplant. vol. 6, supp. 2. Blumberg, 1987, Behaviour of β2-microglobulin in patients with chronic renal failure under going hemodialysis, hemofiltration and continuous ambulatory peritoneal dialysis (CAPD), Clin. Nephrol., 27, 245 Brown, 1980, Dialysis arthropathy: complication of long-term treatment with hemodialysis, Br. Med. J., 292, 163, 10.1136/bmj.292.6514.163 Gejyo, 1988, β2-microglobulin: evidence for a new form of dialysis-associated amyloid protein, Kidney Int., 33, 30 Munoz-Gomez, 1987, Clinical picture of the amyloid arthropathy in patients with chronic renal failure maintained on hemodialysis using cellulose membranes, Ann. Rheum. Dis., 46, 573, 10.1136/ard.46.8.573 Nakazawa, 1987, Synovial amyloidosis of β2-microglobulin type in patients undergoing long-term hemodialysis, Nephron., 44, 379, 10.1159/000184026 Stone, 1989, Beta-2 microglobulin amyloidosis in long term patients, Am. J. Nephrol., 9, 177, 10.1159/000167962 Vincent, 1989, β32 microglobulin, 248 Bommer, 1988, Determinants of plasma β-2 microglobulin concentration: Possible relation to membrane biocompatibility, Nephrol. Dial. Transplant., 3, 284 Van Ypersele de Strihou, 1991, the Working Party on Dialysis Amyloidosis, Effect of dialysis membrane and patient's age on signs of dialysis-related amuloidosis, Kidney Int., 39, 1012, 10.1038/ki.1991.128 Poignet, J-L., Jahns, G., Chauveau, P., Kazatchkine, M. D. & Haeffner-Cavaillon, N., Induction by cytokines of β-2 microglobulin production in cultured mononuclear cells from hemodialyzed patients. 24th annual meeting of the American society for Nephrology Abstracts. Goldblum, 1980, Host defenses and immunologic alterations associated with chronic hemodialysis, Ann. Intern. Med., 93, 597, 10.7326/0003-4819-93-4-597 Chatenoud, 1986, Presence of Preactivated T cells in hemodialyzed patients: their possible role in altered immunity, 83, 7457 Beaurain, 1989, In vivo T cell preactivation in chronic uremic hemodalyzed and non-hemodialyzed patients, Kidney Int., 36, 636, 10.1038/ki.1989.240 Zaoui, 1991, Hemodialysis with cuprophane modulates interleukin-2 receptor expression, Kidney Int., 39, 1020, 10.1038/ki.1991.129 Cappel, 1983, Impaired Immoral and cell mediated immune responses in dialyzed patients after influenza vaccination, Nephron., 33, 15, 10.1159/000182898 Stevens, 1984, Hepatitis B vaccine in patients receiving hemodialysis. Immunologenicity and efficacy, New Engl. J. Med., 311, 496, 10.1056/NEJM198408233110803 Andrew, 1980, Tuberculosis in patients with endstage renal disease, Am. J. Med., 68, 59, 10.1016/0002-9343(80)90166-7 Kurz, 1986, Impaired cellular immune responses in chronic renal failure: evidence for a T-cell defect, Kidney Int., 29, 1209, 10.1038/ki.1986.129